NCT02702986View on ClinicalTrials.gov

Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC)

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

October 31, 2021

Study Completion Date

October 31, 2021

Conditions
Pancreatic Cancer
Interventions
PROCEDURE

immunostimulating Interstitial Laser Thermotherapy

Through a laparotomy a laser device will be inserted into the locally advanced pancreatic cancer.

DEVICE

Laser

Trial Locations (1)

37134

University of Verona Hospital, Verona

All Listed Sponsors
collaborator

Clinical Laserthermia Systems AB

INDUSTRY

lead

Universita di Verona

OTHER

NCT02702986 - Safety and Feasibility of imILT Locally Advanced Pancreatic Cancer (LAPC) | Biotech Hunter | Biotech Hunter